Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Recurrence 1Neoplasm Metastasis 1Head and Neck Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

Radiotherapy 10fludarabine phosphate 9Peripheral Blood Stem Cell Transplantation 8Cyclosporine 7Cyclophosphamide 7Busulfan 7Whole-Body Irradiation 6Melphalan 6Radiofrequency Ablation 5Mycophenolic Acid 5Filgrastim 5Antilymphocyte Serum 5Surveys and Questionnaires 4Surgical Procedures, Operative 4Methotrexate 4Etoposide 4Drug Therapy 4Cisplatin 4fludarabine 3Radiosurgery 3Injections 3Hepatectomy 3Cord Blood Stem Cell Transplantation 3thymoglobulin 2lenvatinib 2Vinblastine 2Videotape Recording 2Thiotepa 2Standard of Care 2Sorafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Recurrence × Ribavirin × Clear all
NCT02308241 2023-01-05

Ribavirin for Patients With Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies

Memorial Sloan Kettering Cancer Center

Phase NA Completed
12 enrolled 9 charts

Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡